Adapting the Mainzer Audiometric Test for Children (MATCH) into another language
Official title: Methodological Guide for the Adaptation of Pediatric Speech Audiometry Tests Into Other Languages
Run by Semmelweis University · NCT07156825 · Data updated 2026-11-12
This project tries to adapt and standardize a children's speech hearing test (MATCH) into another language so clinicians can measure how well 3–6-year-olds with and without hearing loss understand speech.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 2 Years to 7 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Semmelweis University Academic / other |
| Locations | 1 site (Budapest) |
| Status | Recruiting |
| Started | August 5, 2024 |
| Main results expected | May 2026 |
| Study ends | July 2026 |
| Registry record updated | January 26, 2026 |
| Trial ID | NCT07156825 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are preschool-aged children (approximately 3–6 years old) with normal hearing for standardization cohorts or with stable sensorineural hearing loss for diagnostic validation cohorts.
✕Probably not a fit
Children with active upper respiratory infections, known speech-language developmental disorders, or cognitive disorders are excluded and unlikely to benefit from this adapted test.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This methodological observational project provides a step-by-step protocol for translating and standardizing the Mainzer Audiometric Test for Children (MATCH) into another language. The protocol is divided into six phases including selecting test items and validating picture recognizability in children, ensuring linguistic conformity by comparing phoneme distributions to spontaneous speech, and recording materials in an ISO-standard sound-treated environment. It then equalizes item intelligibility via adult speech-recognition testing, standardizes scores on age-stratified cohorts of normal-hearing children, and finally compares speech recognition thresholds to establish diagnostic validity in children with stable sensorineural hearing loss. The work is intended as a transferable framework for languages that currently lack validated pediatric speech-audiometry materials.
Why it matters
Potential benefit: If successful, the protocol would allow reliable speech audiometry for young children in languages that lack validated tests, improving diagnosis and hearing-device fitting.
How similar studies have gone: While individual language-specific adaptations of pediatric speech tests exist, this is presented as the first comprehensive universal protocol that systematically integrates linguistic, phonological, and audiological considerations.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age: limits for age groups: 2-4,5; 4,5-5,5; 5,5-7, respectively. * For control goups: normal hearing verified by pure tone audiometry and tympanometry * For hearing-impairment groups: stable sensorineural hearing loss confirmed by audiological diagnostics Exclusion Criteria: * Children presenting with symptoms of upper respiratory tract infections * Known speech-language developmental disorders * Cognitive disorders
Where it's running
-
Semmelweis University
Budapest, Hungary Recruiting
Study contacts
- Principal investigator: Anita Gaborjan, M.D., Ph.D. — Semmelweis University
- Study coordinator: Gergely P. Vasvari, M.D.
- Email: vasvari.gergely.pal@semmelweis.hu
- Phone: +3614864981
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
WhatsApp AI support vs paper support for first-time hearing aid users
This study tests whether a WhatsApp-based AI support program helps adults with new hearing aids in LMIC communities use and feel confident about their devices better than a paper pamphlet.
-
Hearing and Brain Development in Children and Teens
This observational study tests how hearing care paths (like hearing aids, cochlear implants, brainstem implants, gene therapy, or no intervention) relate to hearing, speech, language, and brain development in kids and teens, with a normal-hearing group for comparison.
-
Web-based auditory training with easy versus hard task settings to improve speech and listening
This project will test whether easy or hard versions of a web-based auditory training program help adults with hearing loss improve speech understanding and everyday listening.
-
Long-term hearing and speech outcomes after cochlear implants
This project will see if cochlear implants improve hearing, speech understanding, and quality of life in Mandarin-speaking patients of all ages before and after surgery.
-
Clemastine plus engineered sound to improve hearing in noisy environments for age-related central auditory processing disorder
This trial will test whether taking clemastine while listening to engineered sounds helps people aged 45–65 with age-related central auditory processing disorder hear better in noisy places.
-
Add Pedmark to cisplatin chemotherapy to prevent hearing loss in men with stage II–III metastatic testicular germ cell tumors
We will test whether adding Pedmark to cisplatin chemotherapy reduces hearing damage in men with stage II–III metastatic testicular germ cell tumors.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.